维普期刊资源整合服务平台（V6.5）

122篇 您的检索式：作者名="Perkovic V"

选中清除导出查看参考文献查看引证文献引用追踪共7页首页上一页第1页下一页末页 /7 跳转

	题名	作者	年代	出处	被引量
1	2型糖尿病患者采用血管紧张素转换酶抑制剂治疗后血清肌酐急性升高及其继续治疗对主要临床结局的影响显示文摘血管紧张素转换酶抑制剂开始治疗后血清肌酐急性升高≥30%时推荐停药。但血清肌酐升高后继续服药或停药对主要临床结局的长期影响仍不明确。在ADVANCE(糖尿病与血管疾病行动:培哚普利-吲达帕胺与达美康缓释片对照评估)试验中,11 140例糖尿病患者在6周活性导入期后随机采用培哚普利-吲达帕胺或安慰剂治疗。	Ohkuma T Jun M Rodgers A Cooper ME Glasziou P Hamet P Harrap S Mancia G Marre M Neal B Perkovic V Poulter N Williams B Zoungas S Chalmers J Woodward M 赵狄练桂丽	2019	中华高血压杂志2019，27，1：	6
2	Anticoagulant thera- pies for the prevention of intravascular catheters malfunction in patients undergoing haemodialysis: systematic review and rec- ta-analysis of randomized, controlled trials显示文摘	Wang AY Ivany JN Perkovic V	2013	Nephrol Dial Transplant2013，28，11：	1
3	Preoperative antisepticsin clean/contaminated maxillofacial and oral surgery:prospectiveandomized study显示文摘	Kosutic D Uglesic V Perkovic D	2009	Int J Oral Maxillofac Surg2009，38，2：	1
4	Rationale, design, and baseline characteristics of the Canagliflozin Cardiovascular Assessment Study (CANVAS)--a randomized placebo- controlled trial显示文摘	Neal B Perkovic V de Zeeuw D	2013	Am Heart J2013，166，2：	1
5	Tae burden of blood pressure-related disease: a neglected priority Hypertension for global health显示文摘	Perkovic V Huxley K Wu Y	2007	50(6): 991-9972007，50，6：	1
6	Corticosteroid Therapy in IgA Nephropathy 显示文摘	Lv J Xu D Perkovic V	2012	Journal of the American Society of Nephrology: JASN2012，23，6：	1
7	Circulating bonemorphogenetic protein-7 and transforming growth factor-^1are better predictors of renal end points in patients withtype 2 diabetes mellitus显示文摘	Wong MG Perkovic V Woodward M	2013	Kidney Int2013，83，2：	1
8	Corticosteroid therapy in IgA nephropathy显示文摘	Lv JC Xu D Perkovic V	2012	J Am Soc Nephrol2012，23，6：	1
9	Parathyroid hormone has a prosclerotic effect on vascular smooth muscle cells显示文摘	Perkovic V Hewitson TD Kelynack KJ	2003	Kidney Blood Press Res2003，26，1：	1
10	Renal and cardio-protective effects of direct renin inhibition: a systematic literature review显示文摘	Lambers Heerspink HJ Perkovic V de Zeeuw D	2009	J Hypertens2009，27，12：	1
11	Aspirin is beneficial in hypertensive patients with chronic kidney disease:a post-hoc subgroup analysis of a randomized controlled trial显示文摘	JARDINE M J NINOMIYA T PERKOVIC V	2010	J Am Coll Cardiol2010，56，12：	1
12	HMG CoA reductase inhibitors(statins) for people with chronic kidney disease not requiring dialysis显示文摘	Navaneethan SD Pansini F Perkovic V		0，，：	1
13	Efficacy and safety of canagliflozin, an inhibitor of sodium-glucose cotransporter 2, when used in conjunction with insulin therapy in patients with type 2 diabetes显示文摘	Neal B Perkovic V de Zeeuw D	2015	Diabetes Care2015，38，3：	1
14	Intensive glucose control improves kidney outcomes in patients with type 2 diabetes显示文摘	Perkovic V Heerspink HL Chalmers J		0，，03：	1
15	Is doubling of serum creatinine a valid clinical ' hard' endpoint in clinical nephrology trials 显示文摘	Lambers Heerspink HJ Perkovic V de Zeeuw D	2011	Nephron Clin Pract2011，119，3：	1
16	Intensive glucose control improves kidney outcomes in patients with type 2 diabetes显示文摘	Perkovic V Heerspink HL Chalmers J		0，，03：	1
17	Rationale, design, and baseline characteristics of the Canagliflozin Cardiovascular Assessment Study(CANVAS)--a randomized placebo-controlled trial显示文摘	Neal B Perkovic V de Zeeuw D et aI	2013	Am Heart J2013，166，2：	1
18	Parathyroid hormone has a prosclerotic effect on vascular smooth muscle cells显示文摘	Perkovic V Hewitson TD Kelynack KJ	2003	Kidney Blood Press Res2003，26，1：	1
19	Epstein-Barr virus-negative aggressive natural killer-cell leukaemia with high P-glycopro-tein activity and phosphorylated extracellular signal-regulated protein kinases 1 and 2 显示文摘	Perkovic S Basic-Kinda S Gasparovic V	2012	Hematol Rep2012，4，3：	1
20	Is low birth weight an ante-cedent of CKD in later life?A systematic review of observationalstudies显示文摘	White SL Perkovic V Cass A	2009	Am J Kidney Dis2009，54，2：	1

返回顶部每页显示：

共7页首页上一页第1页下一页末页 /7 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示